This topic contains a solution. Click here to go to the answer

Author Question: The cost-effectiveness approach is particularly useful a. when the relative merits of competing ... (Read 79 times)

rosent76

  • Hero Member
  • *****
  • Posts: 516
The cost-effectiveness approach is particularly useful
 
  a. when the relative merits of competing proposals are being debated.
  b. in translating effective approaches into their dollar values.
  c. in avoiding the use of dollar values in assessing either the effectiveness or costs associated with a proposal.
  d. in identifying the critical path in a project.

Question 2

The approach to selecting a desirable policy alternative that monetizes (assigns dollar values to) alternatives is
 
  a. cost-effectiveness analysis.
  b. cost-benefit analysis.
  c. systems analysis.
  d. decision analysis.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macagnavarro

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

a

Answer to Question 2

b





 

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library